Cargando…
Glucose-lowering effects of a synbiotic combination containing Pediococcus acidilactici in C. elegans and mice
AIMS/HYPOTHESIS: Modulation of gut microbiota has emerged as a promising strategy to treat or prevent the development of different metabolic diseases, including type 2 diabetes and obesity. Previous data from our group suggest that the strain Pediococcus acidilactici CECT9879 (pA1c) could be an effe...
Autores principales: | Yavorov-Dayliev, Deyan, Milagro, Fermín I., Ayo, Josune, Oneca, María, Goyache, Ignacio, López-Yoldi, Miguel, Aranaz, Paula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542285/ https://www.ncbi.nlm.nih.gov/pubmed/37584728 http://dx.doi.org/10.1007/s00125-023-05981-w |
Ejemplares similares
-
Pediococcus acidilactici CECT9879 (pA1c) Counteracts the Effect of a High-Glucose Exposure in C. elegans by Affecting the Insulin Signaling Pathway (IIS)
por: Yavorov-Dayliev, Deyan, et al.
Publicado: (2022) -
Antidiabetic Effects of Pediococcus acidilactici pA1c on HFD-Induced Mice
por: Cabello-Olmo, Miriam, et al.
Publicado: (2022) -
Pediococcus acidilactici pA1c(®) Improves the Beneficial Effects of Metformin Treatment in Type 2 Diabetes by Controlling Glycaemia and Modulating Intestinal Microbiota
por: Cabello-Olmo, Miriam, et al.
Publicado: (2023) -
Determination of the optimal enrichment Artemia franciscana with a synbiotic combination of probiotics Pediococcus acidilactici and prebiotic fructooligosaccharide
Publicado: (2017) -
Anti-Obesity Efficacy of Pediococcus acidilactici MNL5 in Canorhabditis elegans Gut Model
por: Barathikannan, Kaliyan, et al.
Publicado: (2022)